Biohaven Ltd. (BHVN) Ownership
BHVN ownership summary
as of October 17, 2026- Institutions
- 95.8% of shares outstanding
- Insiders
- 11.21% of shares outstanding
- Shares outstanding
- 151.0M
- Float
- 116.6M shares available to trade
- Short interest
- 16.14% 19.1M shares short
- Days to cover
- 6.27 short interest up 0.3% vs prior month
- Institutions 95.77%
- Insiders 11.21%
BHVN top institutional holders
20 largest| # | Holder | % of shares | Shares | Value | Change | Reported |
|---|---|---|---|---|---|---|
| 1 | HHG PLC | 11.61% | 17.5M | $189.0M | +16.1M (+1,145.9%) | March 31, 2026 |
| 2 | BlackRock Inc | 8.75% | 13.2M | $142.4M | +2.0M (+17.7%) | June 30, 2026 |
| 3 | Suvretta Capital Management, LLC | 6.81% | 10.3M | $110.9M | — | June 30, 2026 |
| 4 | Stifel Financial Corp | 6.58% | 9.9M | $107.2M | +280 (+0.0%) | June 30, 2026 |
| 5 | Jupiter Topco LLC | 5.68% | 8.6M | $92.5M | +8.6M (0.0%) | June 30, 2026 |
| 6 | Woodline Partners LP | 5.07% | 7.7M | $82.6M | +7.4M (+2,450.1%) | June 30, 2026 |
| 7 | State Street Corp | 4.60% | 6.9M | $74.9M | +328,231 (+5.0%) | June 30, 2026 |
| 8 | D. E. Shaw & Co LP | 2.77% | 4.2M | $45.2M | +1.3M (+47.2%) | June 30, 2026 |
| 9 | AQR Capital Management LLC | 2.75% | 4.2M | $44.7M | +2.2M (+110.1%) | June 30, 2026 |
| 10 | Geode Capital Management, LLC | 2.20% | 3.3M | $35.8M | +555,427 (+20.1%) | June 30, 2026 |
| 11 | FMR Inc | 1.96% | 3.0M | $32.0M | +605,583 (+25.7%) | June 30, 2026 |
| 12 | Royalty Pharma Sub-Manager, LLC | 1.94% | 2.9M | $31.7M | — | June 30, 2026 |
| 13 | Cormorant Asset Management, LLC | 1.73% | 2.6M | $28.1M | +850,000 (+48.3%) | June 30, 2026 |
| 14 | The Goldman Sachs Group Inc | 1.71% | 2.6M | $27.8M | +69,865 (+2.8%) | June 30, 2026 |
| 15 | UBS Group AG | 1.67% | 2.5M | $27.2M | +1.1M (+76.6%) | June 30, 2026 |
| 16 | Vanguard Portfolio Management, LLC | 1.65% | 2.5M | $26.8M | +209,666 (+9.2%) | June 30, 2026 |
| 17 | Balyasny Asset Management LLC | 1.24% | 1.9M | $20.3M | −565,682 (−23.1%) | June 30, 2026 |
| 18 | TCG Crossover Management, LLC | 1.18% | 1.8M | $19.2M | −2.9M (−61.6%) | June 30, 2026 |
| 19 | Nuveen, LLC | 1.15% | 1.7M | $18.8M | +998,586 (+133.9%) | June 30, 2026 |
| 20 | Rubric Capital Management LP | 1.14% | 1.7M | $18.6M | +1.7M (0.0%) | June 30, 2026 |
Value at the latest close. Change = shares bought or sold in the latest quarterly filing (13F). In the top 20, 16 holders added 44.0M shares and 2 cut 3.4M.
BHVN top mutual fund and ETF holders
20 largest| # | Holder | % of shares | Shares | Value | Change | Reported |
|---|---|---|---|---|---|---|
| 1 | State Street® SPDR® S&P® Biotech ETF | 2.47% | 3.7M | $40.1M | −71,150 (−1.9%) | September 30, 2026 |
| 2 | iShares Russell 2000 ETF | 2.29% | 3.5M | $37.2M | −39,808 (−1.1%) | September 30, 2026 |
| 3 | Fidelity Select Biotechnology | 1.44% | 2.2M | $23.5M | — | August 31, 2026 |
| 4 | HBM Healthcare Investments AG Ord | 1.28% | 1.9M | $20.9M | — | June 30, 2026 |
| 5 | Fidelity Small Cap Index | 0.97% | 1.5M | $15.7M | +12,148 (+0.8%) | July 31, 2026 |
| 6 | Janus Global Life Science AUSD | 0.84% | 1.3M | $13.7M | −800,477 (−38.6%) | June 30, 2026 |
| 7 | iShares Russell 2000 Growth ETF | 0.83% | 1.2M | $13.5M | −1,580 (−0.1%) | September 30, 2026 |
| 8 | American Funds SMALLCAP World A | 0.77% | 1.2M | $12.6M | — | June 30, 2026 |
| 9 | iShares Biotechnology ETF | 0.66% | 1.0M | $10.8M | −7,592 (−0.8%) | September 30, 2026 |
| 10 | Janus Henderson Global Life Sciences D | 0.63% | 956K | $10.3M | −254,833 (−21.1%) | August 31, 2026 |
| 11 | T. Rowe Price Health Sciences | 0.62% | 941K | $10.1M | — | August 31, 2026 |
| 12 | Janus Henderson Glb Life Scn I2 USD | 0.60% | 910K | $9.8M | −363,711 (−28.6%) | August 31, 2026 |
| 13 | Nuveen Quant Small Cap Equity R6 | 0.55% | 826K | $8.9M | — | August 31, 2026 |
| 14 | Janus Henderson Hrzn Biotec E2 USD | 0.51% | 770K | $8.3M | −853,040 (−52.6%) | June 30, 2026 |
| 15 | Vanguard Russell 2000 ETF | 0.51% | 767K | $8.3M | +18,176 (+2.4%) | August 31, 2026 |
| 16 | CREF Total Global Stock Account R3 | 0.51% | 764K | $8.2M | +279,350 (+57.7%) | July 31, 2026 |
| 17 | Schwab US Small-Cap ETF™ | 0.43% | 654K | $7.0M | +441 (+0.1%) | September 30, 2026 |
| 18 | Fidelity Extended Market Index | 0.42% | 639K | $6.9M | −4,629 (−0.7%) | August 31, 2026 |
| 19 | Simplify Health Care ETF | 0.36% | 551K | $5.9M | — | September 30, 2026 |
| 20 | Vanguard Strategic Equity Inv | 0.32% | 491K | $5.3M | — | June 30, 2026 |
Funds report holdings monthly or quarterly; dates differ by fund.
BHVN insider transactions
latest 4| Date | Name | Transaction | Price | Shares | Value |
|---|---|---|---|---|---|
| 2025-11-17 | George C Clark | Buy | $8.52 | 17,000 | $144,840 |
| 2025-11-13 | Gregory Bailey | Buy | $7.50 | 400,000 | $3.0M |
| 2025-11-13 | John W Childs | Buy | $7.50 | 3,333,333 | $25.0M |
| 2025-11-13 | Vlad Coric | Buy | $7.50 | 666,666 | $5.0M |
Reported trades by company officers, directors and other filers (including disclosures by members of Congress where EODHD lists them). "—" where the filing gives no share count.
BHVN shares outstanding
Year-end shares outstanding, adjusted for splits.
Who owns BHVN
Institutional investors own 95.8% of Biohaven's shares and insiders 11.21%. The largest holder is HHG PLC with 11.61% of the shares (17.5M), as of March 31, 2026. Among the top 20 institutions, 16 added shares and 2 reduced their stake in the latest filings. Short interest is 16.14% of the float, or 6.27 days of average trading volume. The share count rose 992.6% since 2015.
Related: BHVN analyst forecast, BHVN key metrics. See the BHVN stock overview for the latest quote and news.
BHVN ownership FAQ
Who owns the most Biohaven stock?
The largest shareholders of Biohaven are HHG PLC (11.61%), BlackRock Inc (8.75%), Suvretta Capital Management, LLC (6.81%), Stifel Financial Corp (6.58%), Jupiter Topco LLC (5.68%).
What percentage of Biohaven is owned by institutions?
Institutions hold 95.8% of Biohaven's shares outstanding; insiders hold 11.21%.
Which funds own Biohaven?
The largest fund holders of Biohaven are State Street® SPDR® S&P® Biotech ETF (2.47%), iShares Russell 2000 ETF (2.29%), Fidelity Select Biotechnology (1.44%), HBM Healthcare Investments AG Ord (1.28%), Fidelity Small Cap Index (0.97%).
What is Biohaven's short interest?
19.1M shares of Biohaven were sold short, 16.14% of the float; at the average daily volume it would take 6.27 days to cover.
Are insiders buying or selling Biohaven?
Of the latest 4 reported insider transactions in Biohaven (since November 13, 2025), 4 were purchases and 0 were sales.
How many shares of Biohaven are outstanding?
Biohaven has 151.0M shares outstanding, of which 116.6M are in the public float.